Alicja Copik’s story about natural cancer-killing cells illustrates one of the paths university research can take to the marketplace where it can change lives.

Cancer-fighting Technology Developed at UCF Licensed to French Pharmaceutical Giant

By: Zenaida Gonzalez Kotala on

One of the biggest pharma companies in the world will use a nanoparticle technology developed at UCF in hopes of coming up with new blood cancer treatments.

In May,  a cell-based cancer immunotherapy that utilizes a nanoparticle developed at UCF to stimulate a patient’s natural cancer-killing cells headed to Phase II clinical trial.

College of Medicine Associate Professor Alicja Copik and her team developed the technique in 2016 and then co-founded the company CytoSen to take the concept to market. In 2019, the company was acquired by Netherlands-based bio-pharmaceutical firm Kiadis Pharma, which saw the potential to develop new treatment options for cancer patients.

Last week, Kiadis licensed a bundle of technologies – including the one developed at UCF – to Sanofi in a deal estimated at about $1 billion. If the technologies advance through clinical trials and are approved, royalties would follow from commercial sales of products on the market.

Sanofi is based in France and employs more than 100,000 people in 100 countries. The company has 91 products in clinical trials. In 2019, it was ranked the eighth largest pharma company in the world based on sales of about $27.7 billion.

“The licensing of Kiadis’ CD38KO K-NK cells is particularly exciting for Sanofi since we will be studying this cell-based therapeutic with our recently FDA-approved treatment for patients with difficult-to-treat multiple myeloma, in hopes of bringing even more options to these patients with this hematologic cancer,” John Reed, the global head of research for Sanofi, says in a press release. “At Sanofi, we are committed to pioneering treatments that address unmet healthcare challenges. Innovative collaborations, such as this partnership with Kiadis, have the potential to expand the clinical benefits of our medicines by combining them with synergistic partnered therapeutics to deliver improved outcomes for patients.”

Natural killer (NK) cells are part of the body’s defense system and act as an army to protect us from invaders such as viruses and infections. Copik discovered a way to make NK cells even more powerful – by stimulating them with nanoparticles that multiply them and heighten their killing ability – and then use the cells to fight cancer. “That’s what it is all about,” she says, “giving patients a fighting chance of cancer survival.”

Copik’s story about natural cancer-killing cells illustrates one of the paths university research can take to the marketplace where it can change lives. This is why universities invest in Technology Transfer Offices that help innovations get patented and licensed to industry. The commercialization process can take years.

“Our office is grateful to have the unique opportunity to partner with industry to bring the most promising technological advances developed by our dedicated researchers to market to impact global healthcare and improve quality of life,” says Svetlana Shtrom, UCF’s director of Office of Technology Transfer.

Share This Article

Featured Content image

Chemistry Student Working to Develop Sustainable Technology to Clean Water Worldwide

Nearly 800 million people are without clean drinking water in the world, and for the environmental chemist and second-year doctoral candidate Lorianne Shultz, this is no small problem. In her...

Read More

Featured Content image

UCF Partners with Adobe to Personalize Reading Experiences for Students, Adults

The increase in remote work and e-learning sparked by the COVID-19 pandemic means more people are reading in digital formats, from eye-straining, small-text documents to PDFs that have embedded pictures...

Read More

Featured Content image

Several Knights to Present at Adobe Max’s Free, Virtual Conference This Week

The Adobe Max 2020 Creativity conference kicks off Tuesday and this year the event is completely virtual and free. Celebrities alongside tech gurus will discuss products and the power to...

Read More

Featured Content image

OSIRIS REx Ready to for Touch-n-Go Maneuver on Tuesday, Oct. 20

Four years after it launched, NASA’s OSIRIS REx NASA mission is closing in on its big day. On Oct. 20, the spacecraft is scheduled to complete its touch-and-go move to...

Read More